pravastatin has been researched along with 8-epi-prostaglandin f2alpha in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, TF; Lee, TM; Tsai, CH | 1 |
| Oguogho, A; Sinzinger, H | 1 |
| Averna, MR; Bucciarelli, L; Cefalù, AB; Ciabattoni, G; Davì, G; Davì, V; Ferrante, E; Noto, D; Pettinella, C; Santilli, F | 1 |
| Abe, N; Fujiwara, T; Fukuda, I; Fukui, K; Hanada, H; Higuma, T; Kameda, K; Okumura, K; Osanai, T; Saito, S; Yokoyama, J | 1 |
2 trial(s) available for pravastatin and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin f2alpha formation.
Topics: Anticholesteremic Agents; Blood Pressure; Dinoprost; Echocardiography; F2-Isoprostanes; Female; Humans; Hypercholesterolemia; Hypertrophy, Left Ventricular; Male; Middle Aged; Pravastatin | 2002 |
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
Topics: Anticholesteremic Agents; Arginine; Atherosclerosis; Atorvastatin; Cross-Sectional Studies; Dinoprost; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Pravastatin; Pyrroles; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2007 |
2 other study(ies) available for pravastatin and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Variable influence of statins on isoprostanes in hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Dinoprost; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; Isoprostanes; Lovastatin; Male; Middle Aged; Pravastatin; Pyrroles; Simvastatin; Smoking | 2003 |
Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Dinoprost; Electrophoresis, Polyacrylamide Gel; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Middle Aged; Myocardium; Oxidative Stress; Pericardial Effusion; Pravastatin | 2008 |